AusPAR: Tocilizumab (rch)

Australian Public Assessment Report

AusPAR

AusPAR: Tocilizumab (rch) [PDF, 701.35 KB]

AusPAR: Tocilizumab (rch) [Word, 886.14 KB]

Attachment: Product information: Tocilizumab (rch) [PDF, 486.05 KB]

Attachment: Product information: Tocilizumab (rch) [Word, 127.82 KB]

Attachment: Extract from the Clinical Evaluation Report: Tocilizumab (rch) [PDF, 1.07 MB]

Attachment: Extract from the Clinical Evaluation Report: Tocilizumab (rch) [Word, 2.03 MB]

Device/Product Name

Actemra

Active ingredients

Tocilizumab (rch)

AusPAR Date

13 January 2015

Published

25 February 2015

Submission Number

PM-2013-02398-1-3

Submission Type

Major variation (extension of indications)

Decision

Approved